Differences in Daily Voice Use Measures between Female Patients with Nonphonotraumatic Vocal Hyperfunction and Matched Controls

Autor/inn/en	Van Stan, Jarrad H.; Ortiz, Andrew J.; Cortes, Juan P.; Marks, Katherine L.; Toles, Laura E.; Mehta, Daryush D.; Burns, James A.; Hron, Tiffiny; Stadelman-Cohen, Tara; Krusemark, Carol; Muise, Jason; Fox-Galalis, Annie B.; Nudelman, Charles; Zeitels, Steven; Hillman, Robert E.
Titel	Differences in Daily Voice Use Measures between Female Patients with Nonphonotraumatic Vocal Hyperfunction and Matched Controls
Quelle	In: Journal of Speech, Language, and Hearing Research, 64 (2021) 5, S.1457-1470 (14 Seiten) PDF als Volltext Verfügbarkeit
Zusatzinformation	ORCID (Van Stan, Jarrad H.) ORCID (Toles, Laura E.) ORCID (Mehta, Daryush D.) ORCID (Hillman, Robert E.)
Sprache	englisch
Dokumenttyp	gedruckt; online; Zeitschriftenaufsatz
ISSN	1092-4388
Schlagwörter	Pathology; Physiology; Voice Disorders; Patients; Therapy; Females; Human Body; Quality of Life; Severity (of Disability); Symptoms (Individual Disorders); Measurement Equipment + Suchen Sie Ihr Suchwort? Pathologie; Physiologie; Stimmstörung; Patient; Therapie; Weibliches Geschlecht; Menschlicher Körper; Lebensqualität; Schweregrad; Psychiatrische Symptomatik; Messinstrument
Abstract	Purpose: The purpose of this study was to obtain a more comprehensive understanding of the pathophysiology and impact on daily voice use of nonphonotraumatic vocal hyperfunction (NPVH). Method: An ambulatory voice monitor collected 1 week of data from 36 patients with NPVH and 36 vocally healthy matched controls. A subset of 11 patients with NPVH were monitored after voice therapy. Daily voice use measures included neck-skin acceleration magnitude, fundamental frequency (f[subscript o]), cepstral peak prominence (CPP), and the difference between the first and second harmonic magnitudes (H1-H2). Additional comparisons included 118 patients with phonotraumatic vocal hyperfunction (PVH) and 89 additional vocally healthy controls. Results: The NPVH group, compared to the matched control group, exhibited increased f[subscript o] (Cohen's d = 0.6), reduced CPP (d = -0.9), and less positive H1-H2 skewness (d = -1.1). Classifiers used CPP mean and H1-H2 mode to maximally differentiate the NPVH and matched control groups (area under the receiver operating characteristic curve of 0.78). Classifiers performed well on unseen data: the logit decreased in patients with NPVH after therapy; [greater than or equal to] 85% of the control and PVH groups were identified as "normal" or "not NPVH," respectively. Conclusions: The NPVH group's daily voice use is less periodic (CPP), is higher pitched (f[subscript o]), and has less abrupt vocal fold closure (H1-H2 skew) compared to the matched control group. The combination of CPP mean and H1-H2 mode appears to reflect a pathophysiological continuum in NPVH patients of inefficient phonation with minimal potential for phonotrauma. Further validation of the classification model is needed to better understand potential clinical uses. (As Provided).
Anmerkungen	American Speech-Language-Hearing Association. 2200 Research Blvd #250, Rockville, MD 20850. Tel: 301-296-5700; Fax: 301-296-8580; e-mail: slhr@asha.org; Web site: http://jslhr.pubs.asha.org
Erfasst von	ERIC (Education Resources Information Center), Washington, DC
Update	2024/1/01